FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products. [electronic resource]
- Cytotherapy 06 2018
- 779-784 p. digital
Publication Type: Journal Article
1477-2566
10.1016/j.jcyt.2018.03.039 doi
Biological Products--standards Cooperative Behavior Drug Approval Genetic Therapy--methods Humans Intersectoral Collaboration Inventions--standards Reference Standards Regenerative Medicine--methods Therapies, Investigational--methods Translational Research, Biomedical--methods United States United States Food and Drug Administration